BLT 0.00% 14.0¢ benitec biopharma limited

Panno response on Tribetarna Trial

  1. 2,099 Posts.
    lightbulb Created with Sketch. 38
    Panno response about Tribetarna trial starting ....

    Author’s reply »The role of tubulin in NSCLC is still being investigated by the team. The work published late last year


    http://bit.ly/18MEYO0


    has identified tubulin's mode of action in NSCLC. This is a significant step in understanding the safety profile of Tribetarna and increases the chances of the FDA approving an IND. Assuming that the biodistribution studies are also close to completion, then the IND application should not be too far away. The only drawback that I can envisage is the biodistribution study MAY throw up some new data that needs additional work to prove the safety profile is complete. If this were to be the case, then we would need more information before the impact of any such findings could be assessed.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
0.00(0.00%)
Mkt cap $35.98M
Open High Low Value Volume
14.0¢ 14.5¢ 14.0¢ $9.611K 68.02K

Buyers (Bids)

No. Vol. Price($)
3 156122 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 101471 2
Last update - 13.56pm 07/12/2018 (20 minute delay) ?
(live)
Last
14.0¢
  Change
0.00 ( 3.45 %)
Open High   Low Volume
14.5¢ 14.5¢   14.0¢ 42506
Last updated 11.37am 07/12/2018 (live) ?
BLT (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.